Tickerplace logo

Tickerplace

Contineum Therapeutics, Inc. Class A Common Stock logo

CTNMContineum Therapeutics, Inc. Class A Common Stock

CTNM Stock Price, Valuation & Chart | Contineum Therapeutics, Inc. Class A Common Stock

Compare
$17.240+0.69 (+4.17%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyCTNM intrinsic valueCTNM calculated fair value vs price
OverviewFinancialsDividendsRatios

CTNM Historical price chart

CTNM Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization648.59M
PE Ratio-9.97
EPS-1.73
Trading Volume298.62K
Today's High/Low17.31/16.59
Dividend Yield0.00
52 Week High/Low17.51/8.6
Shares Outstanding37.62M
CTNM Financial Statement
CTNM Analyst ratings
CTNM Analysis & performance metrics

CTNM Company profile

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience,…

CTNM Management team

Management
Carmine N. Stengone MBA, MSCEO
President, Chief Executive Officer & Director
Austin Chen Ph.D.
Senior Vice President & Head of Research
Timothy R. Watkins M.D., M.Sc.
Chief Medical Officer & Head of Development
Jennifer Patterson
Vice President of Human Resources
Julie S. Iwashita
Senior Vice President of Clinical Operations
Peter T. Slover CPACFO
Chief Financial Officer
Daniel S. Lorrain Ph.D.
Chief Science Officer
Steve E. KunszaboCTO
Senior Director of Investor Relations & Corporate Communications
Total 8 executives

CTNM Frequently asked questions

What is Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Stock Price?

Current stock price of Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock is $17.240. The stock price is +4.17% higher in the session. The intraday range can be seen from this page. Volume of Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock is 298.62K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock price going up or down today?

The stock price of Contineum Therapeutics, Inc. Class A Common Stock (CTNM) can change with earnings, company news, and overall market sentiment. Contineum Therapeutics, Inc. Class A Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Contineum Therapeutics, Inc. Class A Common Stock stock expensive at its current price?

Whether Contineum Therapeutics, Inc. Class A Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CTNM on this page is -9.97. EPS on this page is -1.73. Compare those figures with peers and growth expectations before deciding if the current Contineum Therapeutics, Inc. Class A Common Stock price is justified.

How has the stock price of Contineum Therapeutics, Inc. Class A Common Stock (CTNM) performed historically?

Historical performance for Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CTNM reacted to past earnings and market events.

Should I buy Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock, at this price?

Buying Contineum Therapeutics, Inc. Class A Common Stock (CTNM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.